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Background: Angiogenesis is essential for uterine decidualization, the progesterone-mediated transformation of
the uterus allowing embryo implantation and initiation of pregnancy. In the current study, we define the
vasculature, expression of Notch proteins and Notch ligands, and Notch activity in both endothelial cells and
vascular-associated mural cells of blood vessels in the pre-implantation endometrium and post-implantation
decidua of the mouse uterus.
Methods: We used immunofluorescence to determine the expression of Notch in endothelial cells and mural cells
by co-staining for the endothelial cell marker, CD31, the pan-mural cell marker, platelet-derived growth factor
receptor beta (PDGFR-β), the pericyte markers, neural/glial antigen 2 (NG2) and desmin, or the smooth muscle cell
marker, alpha smooth muscle actin (SMA). A fluorescein isothiocyanate-labeled dextran tracer, was used to identify
functional peri-implantation vasculature. CBF:H2B-Venus Notch reporter transgenic mice were used to determine
Notch activity.
Results: Notch signaling is observed in endothelial cells and pericytes in the peri-implantation uterus. Prior to
implantation, Notch1, Notch2 and Notch4 and Notch ligand, Delta-like 4 (Dll4) are expressed in capillary endothelial
cells, while Notch3 is expressed in the pericytes. Jagged1 is expressed in both capillary endothelial cells and
pericytes. After implantation, Notch1, Notch4 and Dll4 are expressed in endothelial cells of newly formed decidual
capillaries. Jagged1 is expressed in endothelial cells of spiral arteries and a subset of decidual pericytes. Notch
proteins are not expressed in lymphatic vessels or macrophages in the peri-implantation uterus.
Conclusions: We show Notch activity and distinct expression patterns for Notch proteins and ligands, suggesting
unique roles for Notch1, Notch4, Dll4, and Jag1 during decidual angiogenesis and early placentation. These data set
the stage for loss-of-function and gain-of-function studies that will determine the cell-type specific requirements for
Notch proteins in decidual angiogenesis and placentation.
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Angiogenesis, the formation of new vessels from pre-
existing vasculature, is critical in the uterine endometrium
for embryo implantation, maintenance of early pregnancy,
and development of the placenta. After fertilization, angio-
genesis within the uterus occurs simultaneously with stro-
mal cell decidualization, the rapid proliferation and
differentiation of endometrial stromal fibroblasts into
glycogen and lipid rich decidual cells [1–4]. In mice and
humans, the uterine decidua supports early pregnancy
prior to placenta development. The decidua serves as a
scaffold for the newly formed decidual vascular plexus, as
well as the maternal spiral arteries that are remodeled by
embryo-derived trophoblasts during placenta formation.
The decidual vascular plexus serves as the first exchange
apparatus between the maternal circulation and the
embryo and is necessary to maintain pregnancy prior to
placenta formation [5–7]. In mice, inadequate decidual
vascular development results in pregnancy failure by mid-
gestation [7, 8]. In humans, inadequate decidual vascular
development is associated with implantation failure, first
trimester miscarriages, and abnormal placenta formation
and function which leads to preeclampsia and intrauterine
growth restriction [4, 9]. Ovarian estrogen and progester-
one regulate decidua formation; however, the underlying
molecular signaling pathways active in decidual angiogen-
esis have not as yet been fully characterized.
Sprouting angiogenesis is a multi-step process that begins
with endothelial cells (ECs) sprouting out from mature
vessels. ECs then migrate and proliferate to form a new
sprout consisting of a tip cell at the front and neighboring
stalk cells. New sprouts form capillary loops to create the
vessel lumen and recruit vascular mural cells, which include
pericytes and vascular smooth muscle cells (vSMCs), neces-
sary for vessel stabilization [10]. Well-known regulators of
angiogenesis during development and adult life include the
vascular endothelial growth factor (VEGF) and Notch sig-
naling pathways. In mice and non-human primates, VEGF
activates VEGF receptors (VEGFR) to mediate increased
uterine vascular permeability and decidual angiogenesis re-
quired for embryo implantation [5, 6, 11]. We have shown
that inhibition of VEGFR-2, blocks decidual angiogenesis ob-
served at embryonic day 7.5 (E7.5) and results in embryonic
lethality prior to E10.5 [7]. Whereas continuous VEGFR-1
blockade significantly reduces decidual angiogenesis [12] and
VEGFR-3 inhibition moderately reduces decidual angiogen-
esis [7], neither VEGFR-1 nor VEGFR-3 blockade has a not-
able negative effect on pregnancy prior to E10.5.
VEGF and Notch signaling pathways interact to coord-
inate developmental and postnatal angiogenesis [13–15],
angiogenesis in tumors [16], and angiogenesis modeled
in vitro [17–21]. Notch proteins (Notch1, Notch2, Notch3,
and Notch4) are single-pass transmembrane receptors
that interact with membrane-bound ligands of the Delta-like (Dll) (Dll1, Dll3, Dll4) and Jagged (Jag1 and Jag2) fam-
ilies in adjacent cells [22, 23]. In mice, Notch1 and Notch4
are expressed in endothelium of the developing vascula-
ture [24–26] and Notch3 is expressed in mural cells, peri-
cytes and vSMCs [26–28]. In tissues, such as the
developing postnatal retina Notch ligand, Dll1 and Dll4
are expressed in ECs, while Jag1 is expressed in both ECs
and vascular mural cells [23, 29]. Genetic studies demon-
strate that Notch proteins and ligands are essential for
embryonic vascular development [30–32] and maturation
of vSMCs in mice [33, 34] and humans [35, 36].
Given the interactions between the Notch and VEGF
signaling pathways in vascular development, Notch signal-
ing likely functions in mammalian decidual angiogenesis
to coordinate EC VEGFR signaling. A role for Dll4 in vas-
cular development and differentiation in the decidua has
recently been shown. Dll4 mediates decidual angiogenesis
through induction of a tip/stalk phenotype in decidual
ECs, suggesting a requirement for Notch signaling for
proper decidual vascular development [37]. However, a
comprehensive analysis of the expression of Notch pro-
teins and ligands in decidual angiogenesis has yet to be
described. The goal of this study is to define the expres-
sion of Notch proteins and Notch ligands in the peri-
implantation uterus as a framework for genetic studies
that will identify cell-type specific requirements for Notch
signaling in decidual angiogenesis and placenta formation.
Herein, we characterize the distribution of blood and
lymphatic vessels, vascular associated mural cells, and
macrophages in the pre- and post-implantation mouse
uterus and use a fluorescein isothiocyanate (FITC)-labeled
dextran tracer to identify the functional peri-implantation
vasculature. We determine the expression of Notch pro-
teins, Notch1-4, Notch ligands, Dll4 and Jag1, and Notch
activity with respect to ECs and mural cells in the pre-
and post-implantation mouse uterus. Our data provide
strong support for a role for Notch signaling in decidual
angiogenesis and pericyte/EC interactions.
Methods
Animals
The Columbia University Institutional Animal Care and
Use Committee approved protocols used in animal studies.
All mice were maintained on a C57BL/6 background. For
assessment of wild type expression patterns, we used
C57BL/6J virgin female mice and males of proven fertility
(The Jackson Laboratory). The CBF:H2B-Venus transgenic
mouse strain that expresses human histone H2B fused to
yellow fluorescent protein (YFP) Venus in response to
Notch/CSL transcriptional activation was used to deter-
mine Notch activity [38]. Mice were bred; noon on the day
a mating plug was observed was designated embryonic day
(E) 0.5. Pieces of uteri and implantation sites from pregnant
females at E3.5 and E6.5, respectively, were embedded in
Table 1 Antibodies for analysis of the pregnant mouse uterus
Name Host Company Catalog Number Concentration
Primary antibodies
CD11b Rat Abcam ab8878 1:500
CD31 Rat BD Biosciences 553370 1:350
Desmin Rabbit Abcam ab15200 1:500
Dll4 Goat R&D Systems AF1389 1:100
F4/80 Rat eBioscience 14-4801 1:100
Jagged1 extracellular domain Goat R&D Systems AF599 1:100
Hey2 Rabbit Abcam ab25404 1:200
LYVE1 Rabbit Abcam ab14917 1:1000
NG2 Rabbit Millipore AB5320 1:750
Notch1 Goat R&D Systems AF1057 1:200
Notch2 Rabbit Abcam Ab8926 1:500
Notch3 Rabbit Abcam Ab60087 1:50
Notch4 Rb2-2 Rabbit Dr. Kitajewski’s laboratory 1:100
PDGFR-β Rabbit Cell Signaling 3169 1:500
PDGFR-β Rat Abcam Ab91066 1:100
α-SMA Mouse Sigma C6198 1:850
Secondary antibodies
Anti-goat-IgG Alexa-Fluor 594 Donkey Invitrogen A11058 1:800
Anti-rabbit-IgG Alexa-Fluor 594 Donkey Invitrogen A21207 1:800
Anti-rabbit-IgG Alexa-Fluor 488 Donkey Invitrogen A21206 1:800
Anti-rat-IgG Alexa-Fluor 594 Donkey Invitrogen A21209 1:800
Anti-rat-IgG Alexa-Fluor 488 Donkey Invitrogen A21208 1:800
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Co, Ltd, Tokyo, Japan), snap-frozen on dry ice in ethanol
and stored at −80 °C in methylbutane (Sigma-Aldrich).
Histology, immunohistochemistry (IHC) and
immuofluorescence (IF)
7 μm transverse frozen sections through E3.5 uteri
were generated. To visualize implantation sites at
E6.5, 7 μm frozen sections through uteri/implantation
sites, showing inter-embryonic regions and central
parts of the decidua, were generated. Implantation was
confirmed by hematoxylin and eosin (H&E) staining
every 5th section. IHC and IF staining as previously
described [39] was performed at least 3 times and 5
different uterine sections or implantation sites were
analyzed for each antibody. Primary antibodies are
listed in Table 1. The specificity of Notch protein and
ligand primary antibodies was determined by compar-
ing two independent antibodies for identical staining
patterns in serial E9.75 and E10.5 tissue sections [40],
as well as murine ovary sections. For colorimetric
IHC, biotin goat anti-rat IgG (BD Biosciences 559286,
1:750), the avidin/biotin blocking kit (Vector SP-
2001), the Vectastain ABC kit and DAB substrate kit(Vector SK-4100) were used. Sections were counter-
stained with hematoxylin. Secondary antibodies for IF
are listed in Table 1. Vectashield containing with 4’, 6-
diamidino-2-phenylindole (DAPI) (Vector H-1200)
was used for nuclear visualization and mounting.
Dextran perfusion
Mice were given tail vein injections of 200 μl (25 mg/mL)
of FITC-conjugated 40 kDa dextran (Invitrogen D-1820)
at E3.5 and 10 kDa dextran (Invitrogen D-1845) at E6.5
[41–43]. After 10 minutes, animals were euthanized. Uteri
and implantation sites were dissected in cold phosphate
buffered saline, fixed in Carnoy’s solution and embedded
in paraffin wax. Sections (7 μm) were deparaffinized, rehy-
drated and mounted in Vectashield medium containing
DAPI or stained for Notch1 prior to mounting. Dextran
was administered to 3 mice at each stage. Specific staining
was performed at least 3 times and 5 different uterine sec-
tions or implantation sites were analyzed at each stage.
Microscopy
IHC and H&E staining were examined with a Nikon
MICROPHOT-FXA microscope and images were captured
using NIS-Elements D3.10 software. Fluorescent images
Fig. 1 Characterization of blood vessels in the pre-implantation murine uterus. H&E, IHC, double staining IF and fluorescently labeled dextran in
E3.5 transverse uterine sections. Ovals indicate areas of the uteri magnified (B1 – F1). The orientation is the same for all panels; anti-mesometrial
(am) is at the bottom and mesometrial (m) is at the top. (A) H&E at E3.5 highlighting the luminal epithelium (arrows), inner circular and outer
longitudinal myometrium [dashed bracket (myo)], and endometrial stroma (st). (B) CD31+ ECs are detected throughout the endometrial stroma
and myometrium. (C) CD31 and NG2 staining. NG2+ mural cells are associated with CD31+ ECs in the stroma, myometrium and serosa (s). (D)
CD31 and PDGFR-β staining. PDGFR-β+ murals cells are associated with CD31+ ECs in the stroma, myometrium and serosa. (E) CD31 and SMA
staining. SMA labels glandular epithelium (g) and smooth muscle cells in the myometrium and serosa and is not associated with CD31+ ECs in
the stroma. (F) FITC-dextran is detected throughout the endometrial stroma, in both small and large capillaries (F1, arrowheads), and myometrium.
DAPI identifies all nuclei in IF images. Bar in A – E =100 μm. Bar in F = 500 μm. Bar in B1 – F1 = 50 μm.
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scope on an Eclipse Ti microscope stand (Nikon Instru-
ments, Melville, NY). Standard lasers and filters were used
to image DAPI, AlexaFluor 488, and TRITC. Maximum in-
tensity projections are shown.
Results
Characterization of blood vessels in the pre-implantation
murine uterus
Functional blood vessels, including capillaries, arterioles,
and venules, consist of two key interacting cell types, ECs
and vascular mural cells. ECs form the inner lining of the
vessel wall and vascular mural cells, which include peri-
cytes and vSMCs, surround the endothelial tube, provid-
ing structural support, regulating vessel diameter and
aiding in the regulation of blood flow [44]. To characterize
the pattern of vascular mural cells and functional blood
vessels in the uterus before embryo implantation, we
determined the distribution of ECs and mural cells by co-
staining for the EC marker, CD31 and the pan-mural cellmarker, platelet-derived growth factor receptor beta
(PDGFR-β), the pericyte markers, neural/glial antigen 2
(NG2) and desmin, or the vSMC marker, alpha smooth
muscle actin (SMA). Endometrial vessel functionality was
determined by intravenous administration of FITC-labeled
40 kDa dextran into the tail vein of pregnant females
followed by visualization of labeled dextran in uterine ves-
sels, indicating vessel perfusion (Fig. 1).
At E3.5 prior to embryo implantation, CD31+ ECs in
the endometrial stroma, myometrium and serosa are
closely associated with NG2+ and PDGFR-β+ mural cells
(Fig. 1C, D, yellow signal). Magnified areas of the endo-
metrial stroma are representative of the stroma, myome-
trium and serosa (Fig. 1, C1, D1). Endometrial CD31+
vessels are not associated with SMA+ cells (Fig. 1E).
SMA weakly labels glandular epithelia. SMA expression
is seen throughout the myometrium and serosa, likely
staining vSMCs, as well uterine smooth muscle cells
(uSMCs) that also express NG2 and desmin (Fig. 1C, E,
data not shown). Desmin expression is observed
Fig. 2 Characterization of endothelial cells and mural cells in the post-implantation uterus. H&E and double staining IF of E6.5 uterine sections through
implantation sites, showing inter-embryonic regions and central parts of the decidua. Ovals indicate areas of the uteri magnified (B1 – E1). (A) H&E at
E6.5 highlighting the embryo (e), inter-implantation sites (i), myometrium [dashed bracket (myo)], and decidua, which is between the embryo and
dashed line. (B – E) CD31+ ECs are observed throughout the decidua, inter-implantation sites, and myometrium. (B) CD31 and NG2 staining. NG2+
mural cells are associated with CD31+ ECs in the myometrium (boxes) and in the decidua (arrowheads in B1). NG2+ mural cells are abundant in the
anti-mesometrial (am) decidua and sparse in the mesometrial (m) decidua. (C) CD31 and PDGFR-β staining. PDGFR-β+ murals cells are associated with
CD31+ ECs in the anti-mesomestrial decidua and myometrium. PDGFR-β + mural cells are abundant in the anti-mesometrial decidua and sparse in the
mesometrial decidua (D) CD31 and desmin staining. Desmin+ cells are observed throughout the decidua and myometrium. (E) CD31 and SMA staining.
SMA+ smooth muscle cells are observed in the myometrium and are not associated with CD31+ decidual ECs. DAPI identifies all nuclei in IF images.
Bar in A = 100 μm. Bar in B – E = 500 μm. Bar in B1 – E1 = 50 μm.
Fig. 3 Distribution of endothelial cells and patent vessels identified by FITC-dextran in the post-implantation uterus. H&E, IHC and fluorescently
labeled dextran in E6.5 uterine sections. (A) H&E at E6.5 highlighting the embryo (e) and inter-implantation sites (i). (B) CD31+ ECs are abundant in
the decidua and myometrium. (C) H&E at E6.5 highlighting the embryo surrounded by blood filled maternal sinusoids (box 1, C1) and the blood
filled lateral vascular sinuses in the mesometrial decidua (box 2, C2). (D) FITC-dextran is detected in capillaries (D3, arrow) and has extravasated
into sinusoids around the embryo (D1), lateral vascular sinuses in the mesometrial decidua (D2 and D3, arrowhead), and the stroma (D3, asterisk).
DAPI identifies all nuclei in IF images. am, anti-mesometrial; m, mesometrial; s, serosa. Bar in A and B = 100 μm. Bar in C and D = 500 μm. Bar in
A1 and B1, C1, C2, D1 – D3 = 50 μm.
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serosa and does not appear to be a specific marker of
uterine vascular mural cells (data not shown).
The close association of NG2+, PDGFR-β+, and SMA−
pericytes with CD31+ ECs suggests that these vessels are
functional capillaries. Intravenous injection of FITC-
conjugated dextran shows dextran in vascular structures
throughout the pre-implantation endometrial stroma
(Fig. 1F). We conclude that functional capillaries are present
a day prior to embryo implantation. These capillaries are evi-
dent as pericyte-covered CD31+ vessels within the stroma.
Characterization of blood vessels in the post-implantation
murine uterus
At E6.5 after embryo implantation, the decidua is rich with
CD31+ blood vessels necessary to maintain pregnancy prior
to placentation that begins at E7.5 (Fig. 2B – E). In theFig. 4 Characterization of lymphatic vessels and macrophages in the peri-i
(D – F) uterine sections. Ovals indicate areas of the uteri magnified (E1 and
circular and outer longitudinal myometrium [dashed bracket (myo)], endom
throughout the myometrium and serosa, but are not detected in the endo
are abundant throughout the endometrium, myometrium, and serosa, but
embryo (e), inter-implantation sites (i) and myometrium (myo). (E, F) LYVE1
LYVE1 positive staining in the decidua does not have a vascular pattern (E1
abundant throughout the myometrium and serosa, but scattered througho
the myometrium at E6.5 (F, white arrowheads). DAPI identifies all nuclei in IF
Bar in E and F = 500 μm. Bar in E1 and F1 = 50 μm.myometrium and inter-implantation sites, NG2+ cells are
closely associated with CD31+ ECs (Fig. 2B, boxes, yellow
signal). In the decidua, NG2 expression is abundant in the
anti-mesometrial region, but few NG2+ mural cells are as-
sociated with CD31+ ECs (Fig. 2B, arrowheads in B1). A
majority of PDGFR-β+ cells are associated with CD31+ ECs
with the heaviest coverage in the vessels in the anti-
mesometrial decidua, myometrium and serosa (Fig. 2C, yel-
low signal). In contrast, very few NG2+ and PDGFR-β+
mural cells are found in the mesometrial decidua. Desmin
expression is observed throughout the E6.5 implantation
site, in decidual cells and stromal cells and in myometrium
(Fig. 2D). Similar to E3.5, SMA labels vSMC and uSMCs in
the E6.5 myometrium (Fig. 2E). Taken together, NG2+ and
PDGFR-β+ cells associated with CD31+ ECs represent
pericytes that likely have an active role in decidual
angiogenesis.mplantation uterus. H&E and double staining IF of E3.5 (A – C) and E6.5
F1). (A) H&E at E3.5 highlighting the luminal epithelium (arrows), inner
etrial stroma (st) and serosa (s). (B, C) LYVE1+ lymphatics are observed
metrial stroma. CD11b+ macrophages (B) and F4/80+ macrophages (C)
their distribution patterns differ. (D) H&E at E6.5 highlighting the
+ lymphatics are observed throughout the myometrium at E6.5. The
, F1). CD11b+ macrophages (E) and F4/80+ macrophages (F) are
ut the decidua at E6.5. LYVE1+ F4/80+ macrophages are detected in
images. am, anti-mesometrial; m-mesometrial. Bar in A – D =100 μm.
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vessels, we performed FITC-conjugated 10 kDa dextran
studies in E6.5 females. FITC-dextran identifies patent
capillaries within the mesometrial decidua running lat-
erally from the inter-implantation sites to the embryo
(Fig. 3D, D2 and D3). These mesometrial vessels appear
to be leaky as areas of extravasation are readily ob-
served. FITC-dextran extravasation is seen into blood
filled sinusoids in the implantation crypt around the
embryo (Fig. 3D, D1), where CD31 staining is also
present (Fig. 3D, B1), and in the lateral vascular sinuses
(Fig. 3D, D2 and D3). The distribution of FITC-dextran
suggests that functional, patent vessels as well as areas
of increased vascular permeability are present in the
mesometrial decidua, the site of placenta development.Fig. 5 Notch1 (N1) expression in endothelial cells, mural cells and macroph
E3.5 (A – E) and E6.5 (F – J) uterine sections. Ovals indicate areas of the uteri
epithelium (arrows), inner circular and outer longitudinal myometrium [dashed
are observed throughout the endometrial stroma, myometrium and serosa at E
epithelium (g). (B) Notch1 and CD31. Notch1 is expressed in CD31+ ECs. NG2+ m
cells in the stroma, myometrium, and serosa. (E) Notch1 and F4/80. F4/80 labels
are adjacent to Notch1+ cells (arrowheads in E1). (F) H&E at E6.5 highlighting th
Notch1+ cells are observed throughout the decidua and inter-implantation sites
(H) Notch1 and NG2. NG2+ mural cells are associated with Notch1+ cells in the
Notch1+ cells in the decidua. (J) Notch1 and F4/80. F4/80+ macrophages are no
implantation sites. DAPI identifies all nuclei in IF images. am, anti-mesometrial; m
Bar in B1 – E1 and G1 – J1 = 50 μm.Characterization of lymphatic vessels and macrophages in
the peri-implantation uterus
We used lymphatic endothelial hyaluronan receptor-1
(LYVE1) to detect lymphatic vessels [45] and CD11b [46,
47] and F4/80 [48–50] to detect macrophages. At E3.5,
LYVE1+ lymphatic vessels are restricted to the myometrial
and serosal layers of the uterus (Fig. 4B and C) and ex-
cluded from the endometrium and decidua. At E6.5,
LYVE1+ cells are scattered throughout the decidua, without
any apparent vascular pattern and likely do not represent
lymphatic ECs (Fig. 4E, F), as LYVE1 is also expressed by a
subset of macrophages [51]. F4/80 and LYVE1 double posi-
tive cells are observed in the myometrium at E6.5, but not
at E3.5, suggesting that these cells are recruited subsequent
to embryo implantation (Fig. 4F, arrowheads). The decidualages in the peri-implantation uterus. H&E and double staining IF of
magnified (B1 – E1 and G1 – J1). (A) H&E at E3.5 highlighting the luminal
bracket (myo)], endometrial stroma (st) and serosa (s). (B – E) Notch1+ cells
3.5. Low levels of Notch1 are detected in the luminal (arrows) and glandular
ural cells (C) and PDGFR-β+ mural cells (D) are associated with Notch1+
macrophages in stroma, myometrium and serosa. F4/80+ macrophages
e embryo (e), inter-implantation sites (i), and myometrium (myo). (G – J)
at E6.5. (G) Notch1 and CD31. Notch1 is expressed in CD31+ decidual ECs.
decidua. (I) Notch1 and PDFGR-β. PDGFR-β+ mural cells are associated with
t associated with Notch1+ cells in the decidua, myometrium and inter-
, mesometrial. Bar in A and F = 100 μm. Bar in B – E and G – J = 500 μm.
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ing that they are not macrophages.
CD11b+ macrophages and F4/80+ macrophages are
abundant throughout the myometrium and serosa at E3.5
and E6.5 (Fig. 4). These CD11b+ cells may be undifferenti-
ated monocytes, as well as neutrophils or dendritic cells
that also express this marker. Macrophages are abundant
in the endometrial stroma before implantation (Fig. 4B,
C), while their density is reduced throughout the decidua
after implantation (Fig. 4E, F). The staining patterns
suggest that different populations of macrophages exist
within the peri-implantation uterus: a CD11b+ subset andFig. 6 Notch4 (N4) expression in endothelial cells and mural cells in the pe
E6.5 (D – F) uterine sections. Ovals indicate areas of the uteri magnified (B1,
inner circular and outer longitudinal myometrium [dashed bracket (myo)], en
throughout the stroma, myometrium and serosa. Low levels of Notch4 are de
and CD31. Notch4 is expressed in CD31+ ECs in the endometrium (oval) and
in the myometrium and serosa and is not associated with cells expressing No
(i), and myometrium (myo). (E, F) Notch4+ cells are observed throughout the
expressed in CD31+ ECs in the decidua. (F) Notch4 and SMA. Notch4 is not as
DAPI identifies all nuclei in IF images. am, anti-mesometrial; m, mesometrial. B
and F1 = 50 μm.a F4/80+ subset at both E3.5 and E6.5 and a LYVE1+ and
F4/80+ double positive subset in the myometrium at E6.5.
Notch1 expression in the peri-implantation uterus
To define the expression of Notch1 in the peri-
implantation uterus, we stained for Notch1 along with the
EC marker, CD31, the pericyte markers, NG2 and
PDGFR-β or the macrophage marker, F4/80. At E3.5,
Notch1 is expressed predominantly in endometrial CD31+
ECs, while low levels of Notch1 are detected in luminal
and glandular epithelial cells (Fig. 5A – D). At E6.5,
Notch1 is expressed in decidual CD31+ ECs (Fig. 5G) ofri-implantation uterus. H&E and double staining IF of E3.5 (A – C) and
C1, E1, F1). (A) H&E at E3.5 highlighting the luminal epithelium (arrows),
dometrial stroma (st) and serosa (s). (B, C) Notch4+ cells are observed
tected in the luminal (arrows) and glandular epithelium (g). (B) Notch4
myometrium (box). (C) Notch4 and SMA. SMA labels smooth muscle cells
tch4. (D) H&E at E6.5 highlighting the embryo (e), inter-implantation sites
decidua and myometrium at E6.5. (E) Notch4 and CD31. Notch4 is
sociated with SMA+ smooth muscle cells in the myometrium and serosa.
ar in A and D =100 μm. Bar in B, C, E, and F = 500 μm. Bar in B1, C1, E1,
Fig. 7 Location of Notch2 (N2) in relation to endothelial cells and mural cells in the peri-implantation uterus. H&E and double staining IF of E3.5
(A – D) and E6.5 (E – H) uterine sections. Ovals indicate areas of the uteri magnified (B1 – D1, F1 – H1). (A) H&E at E3.5 highlighting the luminal
epithelium (arrows), and myometrium (myo), and endometrial stroma (st). (B – D) Notch2+ cells are observed throughout the stroma, myometrium
and serosa (s), with low levels of Notch2 in endometrial glands (g). (B) Notch2 and CD31. Notch2+ cells in association with CD31+ ECs are scattered
sparsely throughout the endometrium (arrrowhead in B1) and serosa (s). (C) Notch2 and PDGFR-β. Notch2 is not associated with PDGFR-β+ mural cells
in the stroma and myometrium. (D) Notch2 and SMA. SMA+ smooth muscle cells are observed adjacent to Notch2+ cells in myometrium. Some uterine
smooth muscle cells express both Notch2 and SMA. (E) H&E at E6.5 highlighting the embryo (e), inter-implantation sites (i), and myometrium
(myo). (F – H) Notch2+ cells are observed throughout the myometrium. (F) Notch2 and CD31. Notch2 is not expressed in CD31+ decidual
vessels. (G) Notch2 and PDGFR-β. Notch2 is not associated with PDGFR-β in the decidua or myometrium. (H) Notch2 and SMA staining. SMA+
smooth muscle cells are observed adjacent to Notch2+ cells in myometrium. Some uSMCs express both Notch2 and SMA. DAPI identifies all
nuclei in IF images. am, anti-mesometrial; m, mesometrial. Bar in A and E =100 μm. Bar in B – D and F – H =500 μm. Bar in B1 – D1
and F1 – H1 = 50 μm.
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PDGFR-β+ pericytes are found in close association with
Notch1+ ECs at both time points, suggesting that these
pericytes cover Notch1+ ECs in capillaries (Fig. 5C, D, H,
and I). At E6.5, NG2+ and PDGFR-β+ pericyte coverage of
Notch1+ ECs is most complete in the anti-mesometrial
decidua (Fig. 5H and I). F4/80+ macrophages are observed
in between two Notch1+ ECs in the pre-implantation
endometrial stroma (Fig. 5E, arrowheads). In the post-
implantation decidua, F4/80+ macrophages are not associ-
ated with Notch1+ cells (Fig. 5F). In the peri-implantation
uterus, Notch1 is expressed in the decidual capillary endo-
thelium that is covered with NG2+ and PDGFR-β+ peri-
cytes. Prior to implantation, these Notch1 expressing
capillaries make contact with F4/80+ macrophages in the
endometrium. Notch1 labels neither vSMCs, nor uSMCs
in the myometrium and serosa.Notch4 expression in the peri-implantation uterus
To define the expression of Notch4, we stained for
Notch4 and the EC marker, CD31, or the SMC
marker, SMA. At E3.5, Notch4 is expressed in CD31+
ECs throughout the endometrium and in a subset of
large vessels in the myometrium (Fig. 6B, box high-
lights myometrial vessel). Notch4 is not detected in
cells that express SMA in the myometrium and serosa
(Fig. 6C and F). During post-implantation at E6.5,
endothelial Notch4 expression is strongest in the
mesometrial decidua where the placenta will form
(Fig. 6E). Notch4+ cells are also observed in the myo-
metrium and do not express SMA (Fig. 6F). Notch4
is mainly expressed in CD31+ ECs at E3.5 and in de-
cidual ECs at E6.5. Our data show Notch4 expression
in both capillaries and larger vessels in the peri-
implantation uterus.
Fig. 8 Location of Notch3 (N3) in relation to endothelial cells and mural cells in the peri-implantation uterus. H&E and double staining IF of E3.5
(A – D) and E6.5 (E – H) uterine sections. Ovals indicate areas of the uteri magnified (B1 – D1, F1 – H1). (A) H&E at E3.5 highlighting the luminal
epithelium (arrows), inner circular and outer longitudinal myometrium [dashed bracket (myo)], endometrial stroma (st) and serosa (s). (B – D)
Notch3+ cells are observed throughout the myometrium and serosa and in endometrial glands (g). (B) Notch3 and CD31. Notch3 is not expressed
in CD31+ ECs. (C) Notch3 and PDGFR-β. Notch3 is expressed in PDGFR-β+ mural cells in the endometrial stroma (arrowheads in C1). (D) Notch3
and SMA. Notch3 and SMA staining overlaps in the myometrium and serosa. (E) H&E at E6.5 highlighting the embryo (e), inter-implantation sites
(i), and myometrium (myo). (F – H) Notch3+ cells are observed throughout the myometrium. (F) Notch3 and CD31. Notch3 is not expressed in
CD31+ ECs. (G) Notch3 and PDGFR-β. Notch3 is not associated with PDGFR-β in the decidua or myometrium. (H) Notch3 and SMA. Notch3 and
SMA staining overlaps in the myometrium. DAPI identifies all nuclei in IF images. am, anti-mesometrial; m, mesometrial. Bar in A and E =100 μm.
Bar in B – D and F – H =500 μm. Bar in B1 – D1 and F1 – H1 = 50 μm.
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in the peri-implantation uterus
To determine Notch2 and Notch3 expression patterns,
E3.5 and E6.5 uteri were stained for Notch2 or Notch3
and EC marker, CD31 or mural cell markers, PDGFR-β
and SMA. At E3.5, Notch2 expression is observed in a
subset of CD31+ endometrial ECs (Fig. 7B, arrowhead). In
contrast, Notch2 expression is not associated with CD31+
ECs in the E6.5 decidua (Fig. 7F). At both time points,
Notch2 expression does not overlap with the vascular
mural cell marker, PDGFR-β. In the myometrium, Notch2
is expressed in the SMA+ uSMCs of the inner circular and
outer longitudinal fibers (Fig. 7D and H, yellow signal).
The expression pattern of Notch2 in the decidua does not
support a role for Notch2 in decidual angiogenesis.
Notch3 is not expressed by CD31+ ECs in the peri-
implantation murine uterus (Fig. 8B and F). In the E3.5
endometrium, Notch3 is expressed in PDGFR-β+ peri-
cytes (arrowheads in C1) and in luminal and glandular
epithelium, where it is localized apically (Fig. 8B – D).At both pre- and post-implantation time points, Notch3
is strongly expressed in uSMCs throughout the myome-
trium, as well as vSMCs surrounding large arteries
(Fig. 8D and H). Notch3 is restricted to the vascular
mural cells and myometrial SMCs in the peri-
implantation murine uterus. As in other tissues where
Notch3 has been examined [34, 52], Notch3 is a smooth
muscle cell-specific protein in the pre- and post-
implantation uterus.
Angiogenic Notch ligand expression in the peri-
implantation uterus
E3.5 and E6.5 uteri were stained for the angiogenic Notch
ligands, Dll4 and Jag1 and either the EC marker, CD31 or
the pericyte markers, NG2 and PDGFR-β. In the E3.5 pre-
implantation uterus, Dll4 and Jag1 are expressed in endo-
metrial ECs (Figs. 9B and 10B). Dll4+ cells in the E3.5
endometrium are associated with NG2+ and PDGFR-β+
pericytes (Fig. 9C, D). Jag1+ is expressed on NG2+ and
PDGFR-β+ pericytes (Fig. 10C, D, arrowheads highlight
Fig. 9 Expression of Notch ligand, Dll4 in relation to endothelial cells and mural cells in the peri-implantation uterus. H&E and double staining IF of
E3.5 (A – D) and E6.5 (E – H) uterine sections. Ovals indicate areas of the uteri magnified (B1 – D1, F1 – H1). (A) H&E at E3.5 highlighting the
luminal epithelium (arrows), inner circular and outer longitudinal myometrium [dashed bracket (myo)], endometrial stroma (st) and serosa
(s). (B – D) Dll4+ cells are scattered throughout the stroma, myometrium (box) and serosa. (B) Dll4 and CD31. Dll4 is expressed in CD31+
ECs in the endometrial stroma. (C) Dll4 and NG2. NG2+ mural cells are observed adjacent to the Dll4+ cells in the stroma. (D) Dll4 and
PDGFR-β. PDGFR-β+ mural cells surround Dll4+ stromal cells. (E) H&E at E6.5 highlighting the embryo (e), inter-implantation sites (i), and
myometrium (myo). (F – H) At E6.5, Dll4+ cells are observed throughout the decidua, with most Dll4 expression in the anti-mesometrial
decidua. (F) Dll4 and CD31. Dll4 is expressed in CD31+ decidual ECs. (G) Dll4 and NG2. NG2+ mural cells are adjacent to Dll4+ decidual
cells in the anti-mesometrium. (H) Dll4 and PDGFR-β. PDGFR-β+ mural cells are adjacent to Dll4+ decidual cells in the anti-mesometrium.
DAPI identifies all nuclei in IF images. Bar in A and E =100 μm. Bar in B – D and F – H =500 μm. Bar in B1 – D1 and F1 – H1 = 50 μm.
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cidua, most Dll4+ ECs are observed in the anti-mesometrial
region (Fig. 9F). Whereas Dll4 is primarily expressed in
small decidual capillaries, newly formed during decidual
angiogenesis (Fig. 9), Jag1 is expressed in resident spiral ar-
teries in the mesometrial decidua (Fig. 10F, box). At E6.5,
NG2+ and PDGFR-β+ pericytes are still associated with
Dll4+ and Jag1+ cells (Figs. 9G, H and 10G, H). The overlap
of Jag1 and NG2 demonstrates that a subset of pericytes ex-
press Jag1 (Fig. 10G, arrowhead in G1). The different distri-
bution of Jag1+ and Dll4+ cells suggests that Jag1 and Dll4
function in distinct populations of decidual ECs.
Notch activity in ECs and pericytes in the
peri-implantation uterus
To determine Notch activity in the peri-implantation
uterus, female CBF:H2B-Venus Notch reporter mice
were mated to wild-type males. YFP expression was used
to determine Notch signaling activity in CD31+ decidual
ECs and PDGFR-β+ pericytes. At E3.5, Notch activity is
observed in CD31+ ECs in the endometrium andmyometrium (Fig. 11B, B1), in luminal and glandular
epithelial cells (Fig. 11B and C, arrowheads), and in a
subset of PDGFR-β+ pericytes (Fig. 11C, C1). At E6.5,
the H2B-Venus transgene is expressed in CD31+ ECs of
decidual capillaries (Fig. 11E, E1), CD31+ ECs of myo-
metrial vessels (Fig. 11E) and in a subset of PDGFR-β+
pericytes in the anti-mesometrial decidua (Fig. 11F, F1).
Thus, Notch activity is observed in ECs and pericytes in
the peri-implantation uterus.
We assessed the expression of Hey2, a downstream ef-
fector of Notch signaling, in CD31+ ECs and SMA+ SMCs
in the peri-implantation uterus. Hey2 is not expressed by
CD31+ ECs in the peri-implantation murine uterus
(Fig. 12B and E). At both pre- and post-implantation time
points, Hey2 is strongly expressed in uSMCs throughout
the myometrium (Fig. 12C and F), as well as vSMCs sur-
rounding large arteries (Fig. 12C, C1, arrowhead).
Discussion
Transformation of the pre-implantation E3.5 uterine
endometrium to the post-implantation E6.5 uterine
Fig. 10 Expression of Notch ligand, Jagged1 (Jag1) in relation to endothelial cells and mural cells in the peri-implantation uterus. H&E
and double staining IF of E3.5 (A – D) and E6.5 (E – H) uterine sections. Ovals indicate areas of the uteri magnified (B1 – D1, F1 – H1).
(A) H&E at E3.5 highlighting the luminal epithelium (arrows), inner circular and outer longitudinal myometrium [dashed bracket (myo)],
endometrial stroma (st) and serosa (s). (B – D) Jag1+ cells are observed throughout the endometrial stroma and in the myometrium
(boxes). (B) Jag1 and CD31. Jag1 is expressed in CD31+ ECs in the stroma and myometrium. (C) Jag1 and NG2. Jag1 is expressed on a
subset of NG2+ mural cells in the stroma (arrowheads in C1). (D) Jag1 and PDGFR-β. Jag1 is expressed on a subset of PDGFR-β+ mural
cells in the stroma (arrowheads in D1). (E) H&E at E6.5 highlighting the embryo (e), inter-implantation sites (i), and myometrium (myo).
(F – H) At E6.5, Jag1+ cells are observed in decidua and myometrium. (F) Jag1 and CD31. Jag1 is expressed in CD31+ ECs of spiral arteries
(box) in the mesometrial decidua and in large vessels in the anti-mesometrial decidua and myometrium. (G) Jag1 and NG2 staining. Jag1
is expressed on a subset of NG2+ mural cells in the mesometrial decidua (arrowhead in G1). (H) Jag1 and PDGFR-β. PDGFR-β+ mural cells surround
Jag1+ cells in the decidua. DAPI identifies all nuclei in IF images. am, anti-mesometrial; m, mesometrial. Bar in A and E =100 μm. Bar in B – D and
F – H =500 μm. Bar in B1 – D1 and F1 – H1= 50 μm.
Shawber et al. Vascular Cell  (2015) 7:9 Page 12 of 17decidua requires angiogenesis and vascular remodeling to
increase vascular permeability, and immune/inflammatory
changes. This vascularization process assures successful
embryo implantation and placenta formation [1, 2].
Herein we show that prior to implantation, most vessels
in the uterine endometrium are capillaries, defined as
CD31+ ECs covered by NG2+/PDGFR-β+ pericytes and
lacking SMA expression. Macrophages are abundant
throughout the endometrium, myometrium and serosa,
whereas lymphatic vessels are restricted to the myome-
trium and serosa. After implantation, we found patent
vessels lateral to the embryo running between the inter-
implantation sites and the embryo. NG2+ and PDGFR-β+
pericytes are most abundant on newly formed decidual
capillaries in the anti-mesometrial decidua. It is plausible
that vessels in the mesometrial decidua, the site of vascu-
lar remodeling during placenta formation, may not require
extensive pericyte coverage. Alternatively, a different
population of pericytes, that does not express NG2, butmay express desmin, could support the mesometrial ves-
sels that do not express NG2. However, desmin is also
expressed in the stromal cells and decidual cells and thus
it is not possible to discriminate between desmin+ peri-
cytes and stromal cells.
We hypothesized that Notch proteins and ligands
would be differentially expressed in the vasculature and
vascular associated mural cells of the pre-implantation
uterus and post-implantation uterine decidua, reflecting
their possible functions during decidualization. Prior to
implantation, Notch1, Notch2 and Notch4 are expressed
in the ECs and Notch3 is expressed in pericytes (Table 2).
Notch1 EC expression is observed in the perfused capil-
laries containing FITC-labeled dextran. The Notch li-
gands, Dll4 and Jag1 are expressed in a subset of ECs,
while Jag1 expression is observed in a subset of pericytes
(Table 2). These Notch proteins and ligands are thus
associated with pre-implantation endometrial capillaries.
After implantation, we find Notch1, Notch4, Dll4, and
Fig. 11 Notch activity in endothelial cells and mural cells in the peri-implantation uterus. (A) H&E at E3.5 highlighting the luminal epithelium (arrows),
inner circular and outer longitudinal myometrium [dashed bracket (myo)] and endometrial stroma (st). (B, C) IF of sections through the uterus of
CBF:H2B-Venus Notch reporter mice enabled assessment of Notch activity at E3.5. Ovals indicate areas of the uteri magnified (B1, C1). (B) Notch activity
was observed in CD31+ ECs (red) in the stroma (B1), myometrium, and glandular epithelium (arrowheads). (C) Notch activity was observed in PDGFR-β+
mural cells in the stroma (C1) and myometrium. (D) H&E at E6.5 highlighting the embryo (e), inter-implantation sites (i), and myometrium (myo). (E, F) IF of
sections through implantation sites of female CBF:H2B-Venus Notch reporter mice at E6.5. Ovals indicate areas of the uteri magnified (E1, F1). (E) Notch
activity was observed in CD31+ ECs of decidual capillaries (E1) and myometrial vessels. (F) Notch activity was observed in PDGFR-β+ mural
cells in the anti-mesometrial decidua. DAPI identifies all nuclei in IF images. am, anti-mesometrial; m, mesometrial. Bar in A and D
=100 μm. Bar in B, C, E, and F = 500 μm. Bar in B1, C1, E1, and F1 = 100 μm.
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subset of pericytes (Table 2). We observe EC Dll4 in the
angiogenic vessels of the decidua (Table 2), consistent
with the role of Dll4 in newly forming sprouts during
angiogenesis [37]. Notch2, Notch3 and Notch4 are
expressed in the peri-implantation myometrium. These
data provide an essential foundation for conducting
mechanistic studies to define the roles of individual
Notch family members in decidual angiogenesis and
placentation.
Notch1 and Notch1/Notch4 mutant embryos have
lethal angiogenic defects, with more severe phenotypes
in Notch1/Notch4 double mutants [30]. Endothelium-
specific activation of Notch1 or Notch4 and disruption
of Notch signaling within the vasculature [24, 31, 32]also results in embryonic lethality by mid-gestation with
defects in fetal angiogenesis. These mutants reveal the
importance of Notch1 and Notch4 in formation of fetal-
derived embryonic and placental components. Notch1
has been previously been reported to be expressed in
mouse and primate maternal uterine stromal cells dur-
ing decidualization [53, 54]. The contribution of Notch1
and Notch4 signaling to maternal-derived placental vas-
cular components or the pre-placental decidual vascula-
ture has not as yet been investigated. We show that
Notch1 is expressed in capillaries and excluded from
macrophages in the peri-implantation uterus. Notch1+
ECs are uniformly distributed throughout the decidua,
while Notch4 expression in ECs is more abundant in the
mesometrial decidua. The partially overlapping
Fig. 12 Expression of Notch effector protein, Hey2, in relation to endothelial cells and mural cells in the peri-implantation uterus. H&E and double
staining IF of E3.5 (A – C) and E6.5 (D – F) uterine sections. Ovals indicate areas of the uteri magnified (B1, C1, E1 and F1). (A) H&E at E3.5
highlighting the luminal epithelium (arrows), inner circular and outer longitudinal myometrium [dashed bracket (myo)], endometrial stroma (st)
and serosa (s). (B, C) Hey2+ cells are observed throughout the myometrium and serosa. (B) Hey2 and CD31. Hey2 is not expressed in CD31+ ECs
(B1). (C) Hey2 and SMA. Hey2 and SMA staining overlaps in the myometrium and serosa (C1). (D) H&E at E6.5 highlighting the embryo (e),
inter-implantation sites (i), and myometrium (myo). (E, F) Hey2+ cells are observed throughout the myometrium. (E) Hey2 and CD31. Hey2
is not expressed in CD31+ ECs of decidual capillaries (E1). (F) Hey2 and SMA. Hey2 and SMA staining overlaps in the myometrium (F1).
DAPI identifies all nuclei in IF images. am, anti-mesometrial; m, mesometrial. Bar in A and D =100 μm. Bar in B, C, E, and F =500 μm. Bar
in B1, C1, E1 and F1 = 100 μm.
Table 2 Summary of Notch activity and expression in the peri-implantation mouse uterus
Notch signaling Notch1 Notch2 Notch3 Notch4 Dll4 Jag1
E3.5 Pre-implantation
Endothelial cells X X X X X X
Pericytes X X X
vSMCs X X
uSMCs X X X
E6.5 Post-implantation
Endothelial cells X X X X X
Pericytes X X
vSMCs X X
uSMCs X X X
uSMCs, uterine smooth muscle cells; vSMCs, vascular smooth muscle cells
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Notch1 and Notch4 may have some functionally redun-
dancy in decidual angiogenesis. Further, active Notch
signaling in both decidual ECs, which express Notch1
and Notch4, and pericytes suggests that the Notch path-
way has a fundamental role in decidual angiogenesis.
Homozygous null mutants of Jag1 and Dll4 die during
embryogenesis due to vascular defects [26, 55–58]. The
umbilical artery and placental blood vessels are decreased
in size in Dll4 heterozygous mutant embryos [59]. The re-
quirement for Dll4-mediated signaling in decidual angio-
genesis was recently investigated [37]. Peri-implantation
administration of a Dll4 blocking antibody resulted in in-
creased, but non-productive decidual angiogenesis that
compromised pregnancies by E9.5, with very few embryos
surviving to E13.5 [37]. In this model, Dll4-mediated sig-
naling was blocked during decidualization, however it is
unclear whether subsequent placentation was affected,
leading to the abnormal embryonic development ob-
served. Our finding of Dll4 in capillaries in the anti-
mesometrial uterine decidua supports the finding that
Dll4 signaling is required for proper decidual angiogenesis.
Jag1 is expressed in decidual ECs of maternal spiral arter-
ies and in pericytes. The different expression patterns of
Dll4 and Jag1 in the decidual vasculature suggest unique
functions for these Notch ligands.
During pregnancy, the lymphatic vasculature is be-
lieved to play a role in regulating the fluid balance
between the maternal and fetal compartments and in
maintaining maternal tolerance of the semi-allogeneic
fetus [45, 60, 61]. There is general agreement that the
myometrium and serosa of both humans and mice
contain lymphatic vessels [60, 62, 63]. Whereas
LYVE1+ lymphatics have not been detected in the
endometrium of the non-pregnant human uterus [60,
64], podoplanin+ lymphatics are abundant in the
endometrium basalis, the region directly adjacent to
the myometrium and sparse in the endometrium
functionalis, the region that is shed during menses
[63]. LYVE1+ lymphatics are prominent in the decidua
during all trimesters of human pregnancy, but have
not been detected in the murine decidua [60]. Simi-
larly, we do not observe LYVE1+ lymphatic vessels in
the peri-implantation murine decidua. Further investi-
gation with additional lymphatic markers is necessary
to confirm the difference between humans and mice.
Pregnancy is associated with an influx of macro-
phages into the uterus [65, 66]. Macrophages are pro-
posed to function in coordinating the maternal
immune response, in apoptosis and tissue remodeling
at the maternal-fetal interface, as well as in promot-
ing angiogenesis [67, 68]. Macrophages are recruited
into the endometrium during the peri-implantation
period such that decidual macrophages are the secondmost abundant immune cell population at the im-
plantation site, comprising 20-30 % of immune cells
in the uterine decidua [69, 70]. Whereas CD11b is
expressed by myeloid cells other than macrophages,
F4/80 is expressed by mature macrophages [46, 50].
F4/80 is commonly used to identify macrophages in
the female reproductive tract [12, 71–73]. We re-
cently showed that VEGFR-1+ ECs are often in direct
contact with CD11b+ monocytes/macrophages and
F4/80+ macrophages in the peri-implantation uterus
[12]. Blockade of VEGFR-1 significantly decreases
both the number macrophages in the decidua of E7.5
pregnant mice, likely as an indirect result of the de-
crease in VEGFR-1 function in ECs [12]. Here we
show F4/80+ macrophages in direct contact with
Notch1+ vessels prior to implantation. Available data
suggest that macrophages do not have an obligatory
role in uterine decidualization and embryo implant-
ation [12, 71]. However, macrophages are implicated
in trophoblast invasion and spiral artery remodeling
during placental development [74, 75].
Conclusions
Taken together, our findings support unique roles for
Notch1, Notch4 and angiogenic ligands, Dll4 and Jag1 in
decidual angiogenesis. Abnormal decidual angiogenesis
can result in spontaneous miscarriages early in pregnancy
or have adverse “ripple effects” throughout pregnancy,
leading to abnormal placentation, fetal growth restriction,
and/or preeclampsia [1]. Proper trophoblast invasion of
maternal spiral arteries in the uterine decidua is integral
to placenta formation. Notch proteins are implicated in
EC-trophoblast interactions during this vascular remodel-
ing in the uterine decidua [76]. Our data set the stage for
genetic studies to evaluate the requirement for Notch sig-
naling in decidual angiogenesis and early placentation.
Additional files
Additional file 1: Figure S1. Notch1 expression in patent capillaries in
the pre-implantation uterus at E3.5. Notch1 expression is detected in ca-
pillaries containing FITC-dextran. The area in the rectangle is magnified
and shown in panels on the right. DAPI identifies all nuclei. Scale bar =
50 μm. (JPG 373 kb)
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